C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 120 filers reported holding C4 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $81 | -12.0% | 43,614 | +30.7% | 0.00% | – |
Q2 2023 | $92 | -37.8% | 33,368 | -29.5% | 0.00% | – |
Q1 2023 | $148 | -75.8% | 47,363 | -54.3% | 0.00% | – |
Q4 2022 | $611 | -99.9% | 103,648 | +37.8% | 0.00% | -100.0% |
Q3 2022 | $660,000 | +2100.0% | 75,240 | +1782.9% | 0.00% | – |
Q2 2022 | $30,000 | -95.5% | 3,996 | -85.5% | 0.00% | -100.0% |
Q1 2022 | $670,000 | – | 27,643 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |